Regenicin, Inc. reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported net loss was USD 0.277514 million compared to USD 0.154125 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 15.35K | |
+7.76% | 113B | |
+10.67% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.67% | 17.24B | |
+6.72% | 14.29B | |
+35.79% | 12.52B |
- Stock Market
- Equities
- RGIN Stock
- News Regenicin, Inc.
- Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022